Dermatology News

A “large proportion” of patients with psoriatic arthritis fail to reach treatment targets despite medication, with residual musculoskeletal and skin disease frequently observed, according to data published in Rheumatology and Therapy.

The presence of cardiac troponin I may indicate a risk for atherosclerosis in patients with psoriatic disease independently from traditional cardiovascular risk factors, according to data published in Arthritis and Rheumatology.

Patients with psoriatic arthritis or ankylosing spondylitis who received once daily upadacitinib 15 mg experienced improvements in pain measures through 1 year, according to data published in RMD Open.

Results from a quality-improvement study showed that primary care-based melanoma screening correlated with an increased detection of thin melanoma, according to data published in JAMA Dermatology.

The diagnosis, treatment, and long-term monitoring of patients with autoinflammatory type 1 interferonopathies require a multidisciplinary approach, according to joint guidelines released by EULAR and the American College of Rheumatology.

Patients who take isotretinoin for severe acne did not show signs of adverse neuropsychiatric impacts compared with those who took antibiotics for acne, according to a study.

The FDA has issued warning letters to 12 companies for selling over-the-counter skin lightening products containing hydroquinone, according to a press release.

The FDA has charged Bausch Health with making false or misleading claims about its topical plaque psoriasis cream Duobrii.

Deucravacitinib, a TYK2 inhibitor, was well-tolerated and superior to placebo in improving ACR20 response among patients with psoriatic arthritis, according to data published in the Annals of the Rheumatic Diseases.

Patients with rheumatic and musculoskeletal diseases should engage in both aerobic and strengthening exercises, aiming for at least moderate intensity, according to new EULAR recommendations.